Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Eli Samaha files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bradley J. Gross - $13.07M of STGW open-market activity in the last 12 months
- Eran Broshy - $1.66M of TBPH open-market activity in the last 12 months
- Rhonda Farnum - $1.23M of TBPH open-market activity in the last 12 months
- Frank P. Lanuto - $525K of STGW open-market activity in the last 12 months
- Mark Jeffery Penn - $118K of STGW open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Eli Samaha?
Eli Samaha is a corporate insider, tracked as 10% Owner of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Eli Samaha submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Eli Samaha been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($5.91M) across all tracked filings.
Where can I see all of Eli Samaha's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Eli Samaha and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
